CEP112: A Potential Drug Target Or Biomarker for Various Diseases

Target Name: CEP112

NCBI ID: G201134

CEP112

CEP112: A Potential Drug Target Or Biomarker for Various Diseases

Centrosomal protein 112kDa (CEP112) is a protein that is expressed in various cell types, including neurons, gastrointestinal epithelial cells, and leukemia cells. It is a member of the centrosome complex, which is a protein structure that is found in the center of each cell. The centrosome complex plays a crucial role in the replication and organization of chromosomes during cell division.

Recent studies have identified CEP112 as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and developmental disorders. CEP112 has been shown to be involved in a number of cellular processes that are important for human health, including the development and progression of cancer, the regulation of cell division and differentiation, and the maintenance of cellular structure and stability.

One of the key functions of CEP112 is its role in the regulation of microtubules, which are protein structures that play a central role in the movement of cells and the transport of organelles within cells. Microtubules are made up of two main components: the protein tau and the protein tubulin. Tau is a protein that helps to keep the microtubules in a flexible, organized structure, while tubulin is a protein that helps to keep the microtubules stable.

Studies have shown that CEP112 plays a key role in the regulation of microtubule dynamics and stability. It has been shown to interact with tubulin and to influence the dynamics of microtubule formation and stability. This suggests that CEP112 may be a useful drug target or biomarker for diseases that are characterized by the misregulation of microtubule dynamics and stability, such as cancer, neurodegenerative diseases, and developmental disorders.

Another function of CEP112 is its role in the regulation of cell division and differentiation. Microtubules play a critical role in the regulation of cell division, as they help to ensure that chromosomes are accurately replicated and that the cell divides into two daughter cells. CEP112 has been shown to be involved in the regulation of microtubule dynamics and stability, which suggests that it may be a useful drug target or biomarker for diseases that are characterized by the misregulation of cell division and differentiation, such as cancer.

In addition to its role in the regulation of microtubule dynamics and stability, CEP112 has also been shown to be involved in the regulation of cellular structure and stability. Microtubules help to maintain the structural integrity of the cell, as they provide a framework for the attachment and organization of various cellular structures and organelles. CEP112 has been shown to play a key role in the regulation of microtubule dynamics and stability, which suggests that it may be a useful drug target or biomarker for diseases that are characterized by the loss of cellular structure and stability, such as cancer.

Overall, CEP112 is a protein that has been shown to play a critical role in a number of cellular processes that are important for human health. Its role in the regulation of microtubule dynamics and stability, as well as its involvement in the regulation of cell division and differentiation, makes it a potential drug target or biomarker for a wide range of diseases. Further research is needed to fully understand the functions of CEP112 and to develop effective treatments for diseases that are characterized by the misregulation of microtubule dynamics and stability.

Protein Name: Centrosomal Protein 112

The "CEP112 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CEP112 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets